National Stock Number
6515-01-016-1398
National Stock Number (NSN) 6515-01-016-1398, or NIIN 010161398, (catheter and needle unit,intrave) was assigned February 4, 1976 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.
There is only one manufacturer part number associated with this NSN. One of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 2 suppliers. Today, 2 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over 5 years.
Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Apr 02, 1991, this NSN's acquisition method was noted as: Not established. Not established.
This NSN is assigned to Item Name Code (INC) 29491. [AN ITEM CONSISTING OF A CANNULATED NEEDLE WITH AN INTRAVENOUS CATHETER, AND IT MAY CONTAIN ADDITIONAL COMPONENTS, SUCH AS A HYPODERMIC SYRINGE, NEEDLE GUARD, FLOW CONTROL PLUG, AND THE LIKE. THE CATHETER IS INSERTED INTO THE VEIN BY WAY OF THE NEEDLE'S PUNCTURE, AND IS LEFT IN POSITION FOR CONTINUED INTRAVENOUS ADMINISTRATION AFTER THE NEEDLE IS WITHDRAWN. A SYRINGE, WHEN SUPPLIED, IS USED TO BETTER CONTROL INSERTION OF THE CATHETER NEEDLE UNIT OR FOR BLOOD ASPIRATION.]. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no data in the HMIRS and the NSN is in an FSC not generally suspected of containing hazardous materials. NSN 6515010161398 contains an unknown precious metal.
This NSN is associated to Schedule B 9018390030: bougies, catheters, drains and sondes and parts and accessories. The Schedule B End Use is listed as medicinal equipment. NAICS classification category 339112: surgical and medical instrument manufacturing.
This information was last updated on Jul 01, 2025.